Resources Repository
-
GuidelinesPublication 2011HPV Vaccine Introduction in LMIC's: Guidance on the Use of Cost-Effectiveness Models
This article is a literature review of HPV vaccination models suitable for low-income and middle-income …
This article is a literature review of HPV vaccination models suitable for low-income and middle-income country use to provide information about the feasibility of using such models in a developing country setting. The authors evaluated models in terms of their capacity, requirements, limitations and comparability. Their literature review identified six HPV vaccination models suitable for low-income and middle-income country use and representative of the literature in terms of provenance and model structure. Each model was…
Cost-Effectiveness Analysis | Global | Mathematical Models | Calibration/Validation | Infectious Diseases | Chronic Disease/Risk | Health Systems | Clinical Care | Health/Medicine | Science/Technology -
Lesson/ModuleWeb Portal, Teaching Resource 2011Test is Positive: But What Are the Odds It's Wrong?
This learning module explores real-world applications of probability and statistics in decision-making. It includes a …
This learning module explores real-world applications of probability and statistics in decision-making. It includes a wide range of activities and resources to accompany videos on probability and statistics in diagnostic testing and as evidence in the court of law. These videos aim to help students better understand what questions to ask in order to produce optimal data. Both video-related and alternative practice problems are provided. These activities are recommended to be used together but can…
Global | Probability/Bayes | Test Performance | Government/Law | Health/Medicine | High School | Critical Thinking/Analysis | Decision Making/Leadership | Quantitative Literacy -
ReviewPublication 2003Public Health Policy and Cost-Effectiveness Analysis
This chapter presents an overview of the uses for cost-effectiveness analysis and disease-simulation modeling to …
This chapter presents an overview of the uses for cost-effectiveness analysis and disease-simulation modeling to rigorously evaluate alternatives to reduce mortality from cervical cancer. Scientific advances have provided opportunities over time to revisit strategies for cervical cancer prevention. How to invest health resources wisely, such that public health benefits are maximized-and opportunity costs are minimized-is a critical question in the setting of enhanced cytologic screening methods, human papillomavirus DNA testing, and vaccine development. Developing sound…
Cost-Effectiveness Analysis | Global | Mathematical Models | Infectious Diseases | Chronic Disease/Risk | Health Systems | Policy/Regulation | Health/Medicine